If you think the two non-OB patents are in fact different from the seven OB patents with respect to continuation, please tell us in what way they are different.
The PTO's MPEP will explain to you the difference between a cip and a continuation.
I’m aware of the difference, which should be clear from the post you are replying to.
Perhaps another patent attorney will be able to explain it to you better than I have in the PMs I have sent .
There was nothing deficient in your explanation—you are simply barking up the wrong tree in this instance.
Your opinion is set in concrete.
I’ve done some non-trivial DD on this matter, including asking MNTA’s general counsel for his opinion of the two non-OB patents. Can you say the same?
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”